
NOVIGA is a French company founded in 2018, specializing in digital health solutions focused on screening sleep apnea syndrome through cardiology. Their key product, SPINEO, is an online platform designed for cardiologists to facilitate the detection of obstructive sleep apnea syndrome (OSA) using a simple Holter electrocardiogram (ECG) sensor worn overnight by patients. The platform uses an embedded algorithm to analyze ECG signals and provide rapid, easy-to-interpret screening results, improving patient comfort and physician efficiency. NOVIGA integrates research, innovation, and expertise in electrophysiological signal analysis, machine learning, and predictive models to enhance medical diagnostics within a strict regulatory framework. SPINEO is CE marked as a Class I medical device and is accessible 24/7 from any computer, targeting cardiologists and healthcare professionals. The company is based in Nancy, France, and collaborates with medical equipment providers and research projects, supported by European Union funding.

NOVIGA is a French company founded in 2018, specializing in digital health solutions focused on screening sleep apnea syndrome through cardiology. Their key product, SPINEO, is an online platform designed for cardiologists to facilitate the detection of obstructive sleep apnea syndrome (OSA) using a simple Holter electrocardiogram (ECG) sensor worn overnight by patients. The platform uses an embedded algorithm to analyze ECG signals and provide rapid, easy-to-interpret screening results, improving patient comfort and physician efficiency. NOVIGA integrates research, innovation, and expertise in electrophysiological signal analysis, machine learning, and predictive models to enhance medical diagnostics within a strict regulatory framework. SPINEO is CE marked as a Class I medical device and is accessible 24/7 from any computer, targeting cardiologists and healthcare professionals. The company is based in Nancy, France, and collaborates with medical equipment providers and research projects, supported by European Union funding.
Founded: 2018 (Nancy, France)
Product: SPINEO — ECG-based OSA screening software (CE Class I)
Team: Doctors and engineers specialized in signal analysis and ML
Funding: Recorded non-equity assistance (Dec 12, 2018); total funding reported as 0.00 USD
Screening and evaluation of obstructive sleep apnea using long-term ECG signal analysis.
2018
Medtech / Digital Health
Recorded non-equity assistance funding event
“Incubateur Lorrain and programmatic support from EIT Health and regional innovation programs (Scal'E-nov, Grand Est, Inria) are listed as partners/supporters.”